Smith & Nephew (SNN) Interest Expenses (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Interest Expenses of -$140.0 million for Q4 2025, up 3.45% year-on-year from -$135.3 million in Q4 2024, and up 3.45% on a QoQ basis from -$145.0 million in Q4 2024.
Smith & Nephew (SNN) Interest Expenses (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Interest Expenses for 17 consecutive years, with -$140.0 million the latest figure, recorded in Q4 2025.
- Quarterly Interest Expenses rose 3.45% year-over-year to -$140.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$285.0 million (down 493.75% YoY) and the FY2025 annual result came in at $140.0 million, changed 0.0% from the prior year.
- Interest Expenses grew to -$140.0 million in Q4 2025 per SNN's latest filing, from -$145.0 million in the prior quarter.
- Over the last five years, Interest Expenses for SNN reached as high as $132.0 million in Q4 2023 and fell as low as -$145.0 million in Q4 2024.
- A 5-year average of -$46.0 million and a median of -$42.0 million in 2021 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses jumped 477.14% — and 2024, when it tumbled 209.85%.
- Year by year, Interest Expenses stood at -$42.0 million in 2021, then climbed by 16.67% to -$35.0 million in 2022, then soared by 477.14% to $132.0 million in 2023, then slumped by 209.85% to -$145.0 million in 2024, then gained by 3.45% to -$140.0 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered -$140.0 million, -$145.0 million, and $132.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -140.00 Mn |
| Dec 31, 2025 | -140.00 Mn |
| Dec 31, 2024 | -145.00 Mn |
| Dec 31, 2024 | -145.00 Mn |
| Dec 31, 2023 | 132.00 Mn |
| Dec 31, 2023 | 132.00 Mn |
| Dec 31, 2022 | -35.00 Mn |
| Dec 31, 2022 | -35.00 Mn |
| Dec 31, 2021 | -42.00 Mn |
| Dec 31, 2021 | -42.00 Mn |
| Dec 31, 2020 | -24.00 Mn |
| Dec 31, 2020 | -24.00 Mn |
| Dec 31, 2019 | -65.00 Mn |
| Dec 31, 2019 | -65.00 Mn |
| Dec 31, 2018 | -59.00 Mn |
| Dec 31, 2018 | -59.00 Mn |
| Jun 30, 2018 | 31.00 Mn |
| Jun 30, 2018 | 31.00 Mn |
| Dec 31, 2017 | -57.00 Mn |
| Dec 31, 2017 | -57.00 Mn |